SELLAS Life Sciences Group, Inc. (SLS)

4.49 -0.09 (-1.97%) USD  |  NASDAQ  |  Jan 22, 10:43
More

SELLAS Life Sciences Group Security Sold Not Yet Repurchased (Quarterly)

Security Sold Not Yet Repurchased (Quarterly) Chart

View Security Sold Not Yet Repurchased (Quarterly) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Security Sold Not Yet Repurchased (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Security Sold Not Yet Repurchased (Quarterly) Range, Past 5 Years

View Security Sold Not Yet Repurchased (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Security Sold Not Yet Repurchased (Quarterly) Benchmarks

View Security Sold Not Yet Repurchased (Quarterly) Benchmarks
Start Trial
GT Biopharma, Inc. --
Amicus Therapeutics, Inc. --
Geron Corp. --
Vanda Pharmaceuticals, Inc. --
ADMA Biologics, Inc. --